Sonia Connaughton

Sonia Connaughton received her Ph.D. in Pharmacology from the University College Dublin, Ireland. Following her postdoctoral studies at St Louis University, she spent several years at Cambridge NeuroScience and Applied Biosystems where she focused on the development of assays to monitor ion channels and modulation of G-coupled Protein Receptors. At ImmunoGen, her efforts focused on the development of bioassays for lot release and stability testing for Antibody and Probody-Drug Conjugates. At Sanofi, Sonia leads a bioassay group focused on developing and implementing bioassays to support early and late-stage development for a wide variety of modalities including Monoclonal, Bi and Tri-specific Antibodies, Enzyme replacement therapies and Gene Therapy.